TRC Fundamental Analysis - TEJON RANCH CO

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to TRC. TRC was compared to 64 industry peers in the Real Estate Management & Development industry. The financial health of TRC is average, but there are quite some concerns on its profitability. TRC has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

TRC had positive earnings in the past year.

TRC had a positive operating cash flow in the past year.

TRC had positive earnings in 4 of the past 5 years.

Each year in the past 5 years TRC had a positive operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of 0.47%, TRC is in line with its industry, outperforming 59.38% of the companies in the same industry.

TRC has a better Return On Equity (0.63%) than 60.94% of its industry peers.

		Industry Rank	Sector Rank
ROA	0.47%
ROE	0.63%
ROIC	N/A

ROA(3y)1.27%

ROA(5y)0.93%

ROE(3y)1.56%

ROE(5y)1.15%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

TRC has a better Profit Margin (6.41%) than 78.13% of its industry peers.

In the last couple of years the Profit Margin of TRC has declined.

With a Gross Margin value of 13.32%, TRC is not doing good in the industry: 62.50% of the companies in the same industry are doing better.

In the last couple of years the Gross Margin of TRC has declined.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	6.41%
GM	13.32%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3Y-12.59%

PM growth 5Y-21.37%

GM growth 3Y-35.98%

GM growth 5Y-22.35%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

TRC does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, TRC has about the same amount of shares outstanding.

The number of shares outstanding for TRC has been increased compared to 5 years ago.

Compared to 1 year ago, TRC has a worse debt to assets ratio.

2.2 Solvency

An Altman-Z score of 2.00 indicates that TRC is not a great score, but indicates only limited risk for bankruptcy at the moment.

TRC has a better Altman-Z score (2.00) than 60.94% of its industry peers.

TRC has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.

TRC has a better Debt to Equity ratio (0.19) than 71.88% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.19
Debt/FCF	N/A
Altman-Z	2

ROIC/WACCN/A

WACC8.1%

2.3 Liquidity

A Current Ratio of 2.66 indicates that TRC has no problem at all paying its short term obligations.

TRC has a better Current ratio (2.66) than 67.19% of its industry peers.

TRC has a Quick Ratio of 2.06. This indicates that TRC is financially healthy and has no problem in meeting its short term obligations.

TRC has a Quick ratio of 2.06. This is in the better half of the industry: TRC outperforms 67.19% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	2.66
Quick Ratio	2.06

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

TRC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1729382256910270720.00%, which is quite impressive.

TRC shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -24.17% yearly.

TRC shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 15.71%.

The Revenue has been decreasing by -3.29% on average over the past years.

EPS 1Y (TTM)1729382256910270700%

EPS 3Y-19.39%

EPS 5Y-24.17%

EPS Q2Q%185.71%

Revenue 1Y (TTM)15.71%

Revenue growth 3Y-9.02%

Revenue growth 5Y-3.29%

Sales Q2Q%10.25%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y-155.09%

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year1.29%

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

TRC is valuated quite expensively with a Price/Earnings ratio of 135.25.

TRC's Price/Earnings ratio is in line with the industry average.

TRC is valuated expensively when we compare the Price/Earnings ratio to 26.31, which is the current average of the S&P500 Index.

The Forward Price/Earnings Ratio is negative for TRC. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	135.25
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for TRC!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

TEJON RANCH CO

NYSE:TRC (11/28/2025, 8:03:44 PM)

After market: 16.23 0 (0%)

16.23

-0.02 (-0.12%)

Chartmill FA Rating

GICS SectorReal Estate

GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)

GICS IndustryReal Estate Management & Development

Earnings (Last)11-06 2025-11-06/bmo

Earnings (Next)03-04 2026-03-04/bmo

Inst Owners66.04%

Inst Owner Change5.82%

Ins Owners5.6%

Ins Owner Change0.65%

Market Cap436.42M

Revenue(TTM)46.42M

Net Income(TTM)2.98M

Analysts0

Price Target26.78 (65%)

Short Float %3.67%

Short Ratio9.01

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)148.51%

Min EPS beat(2)-197.03%

Max EPS beat(2)494.06%

EPS beat(4)2

Avg EPS beat(4)40.76%

Min EPS beat(4)-595.05%

Max EPS beat(4)494.06%

EPS beat(8)4

Avg EPS beat(8)44.86%

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)2

Avg Revenue beat(2)12.92%

Min Revenue beat(2)1.52%

Max Revenue beat(2)24.33%

Revenue beat(4)4

Avg Revenue beat(4)11.88%

Min Revenue beat(4)1.52%

Max Revenue beat(4)24.33%

Revenue beat(8)6

Avg Revenue beat(8)-0.15%

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)-16.67%

EPS NQ rev (3m)-16.67%

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)0%

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	135.25
Fwd PE	N/A
P/S	9.4
P/FCF	N/A
P/OCF	47.63
P/B	0.92
P/tB	1.07
EV/EBITDA	N/A

EPS(TTM)0.12

EY0.74%

EPS(NY)-0.06

Fwd EYN/A

FCF(TTM)-2.59

FCFYN/A

OCF(TTM)0.34

OCFY2.1%

SpS1.73

BVpS17.6

TBVpS15.22

PEG (NY)N/A

PEG (5Y)N/A

Graham Number6.89

Profitability

		Industry Rank	Sector Rank
ROA	0.47%
ROE	0.63%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	6.41%
GM	13.32%
FCFM	N/A

ROA(3y)1.27%

ROA(5y)0.93%

ROE(3y)1.56%

ROE(5y)1.15%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3Y-12.59%

PM growth 5Y-21.37%

GM growth 3Y-35.98%

GM growth 5Y-22.35%

F-Score6

Asset Turnover0.07

Health

		Industry Rank	Sector Rank
Debt/Equity	0.19
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	1420.62%
Cap/Sales	169.79%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	2.66
Quick Ratio	2.06
Altman-Z	2

F-Score6

WACC8.1%

ROIC/WACCN/A

Cap/Depr(3y)810.78%

Cap/Depr(5y)692.45%

Cap/Sales(3y)82.92%

Cap/Sales(5y)71.79%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)1729382256910270700%

EPS 3Y-19.39%

EPS 5Y-24.17%

EPS Q2Q%185.71%

EPS Next Y-155.09%

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)15.71%

Revenue growth 3Y-9.02%

Revenue growth 5Y-3.29%

Sales Q2Q%10.25%

Revenue Next Year1.29%

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y40.63%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-2157.8%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-57.21%

OCF growth 3Y71.94%

OCF growth 5Y-2.26%

TEJON RANCH CO / TRC FAQ

Can you provide the ChartMill fundamental rating for TEJON RANCH CO?

ChartMill assigns a fundamental rating of 3 / 10 to TRC.

What is the valuation status of TEJON RANCH CO (TRC) stock?

ChartMill assigns a valuation rating of 0 / 10 to TEJON RANCH CO (TRC). This can be considered as Overvalued.

How profitable is TEJON RANCH CO (TRC) stock?

TEJON RANCH CO (TRC) has a profitability rating of 3 / 10.

Can you provide the PE and PB ratios for TRC stock?

The Price/Earnings (PE) ratio for TEJON RANCH CO (TRC) is 135.25 and the Price/Book (PB) ratio is 0.92.

What is the financial health of TEJON RANCH CO (TRC) stock?

The financial health rating of TEJON RANCH CO (TRC) is 5 / 10.

TEJON RANCH CO (TRC) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

TEJON RANCH CO / TRC FAQ

Can you provide the ChartMill fundamental rating for TEJON RANCH CO?

What is the valuation status of TEJON RANCH CO (TRC) stock?

How profitable is TEJON RANCH CO (TRC) stock?

Can you provide the PE and PB ratios for TRC stock?

What is the financial health of TEJON RANCH CO (TRC) stock?